PT430 – Maya Albert – Psychedelics for Eating Disorders, Davos' House of Psychedelics, and The Future of the Synthesis Institute

PT430 – Maya Albert – Psychedelics for Eating Disorders, Davos' House of Psychedelics, and The Future of the Synthesis Institute

In this episode, Joe interviews Maya Albert: Co-Founder of the Psyched conference, and Director of Operations at Tabula Rasa Ventures and the Synthesis Institute.

She shares her journey of how she became involved in the psychedelic space through her mother, and her personal experience as a patient in a clinical trial on psilocybin for the treatment of anorexia – a much more common and deadly affliction than most people realize. She discusses her involvement with the various psychedelic gatherings surrounding Davos and the World Economic Forum, as well as the work she's doing with Tabula Rasa and some of their clients seeking to expand insurance coverage to psychedelic-assisted therapy.

She discusses the Synthesis Institute's recent struggles that shook up the psychedelic space, what they're doing to save the company, how Retreat Guru has helped them, and the implications for the wider psychedelic movement. And she talks about much more: the legality and vetting process for training in Oregon and Colorado; truffles in the Netherlands vs. classic psilocybin; the idea of alcohol as poison and 'Cali sober,' and how can we all be more collaborative and not sling mud at each other?

Click here to head to the show notes page.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT528 – Chronic Pain and Inducing Neuroplasticity With Psychedelics, with Lynn Watkins, Retired USAF, and C.J. Spotswood, PMHNP

PT528 – Chronic Pain and Inducing Neuroplasticity With Psychedelics, with Lynn Watkins, Retired USAF, and C.J. Spotswood, PMHNP

In this episode, Joe and REMAP Therapeutics Founder, Court Wing, host Lynn Watkins: medically retired USAF JAG & Ops Resource Mgmt Specialist; and C.J. Spotswood, PMHNP: principle psychiatric clinicia...

9 Heinä 20241h 8min

PT527 – Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence, with Casey Paleos, MD

PT527 – Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence, with Casey Paleos, MD

In this episode of Vital Psychedelic Conversations, David interviews Casey Paleos, MD: Vital instructor, researcher, psychiatrist with a private practice offering ketamine infusion therapy and KAP, an...

5 Heinä 20241h 19min

PT526 – Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability, with Peter A. Levine, Ph.D.

PT526 – Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability, with Peter A. Levine, Ph.D.

In this episode, Kyle interviews Peter A. Levine, Ph.D.: developer of Somatic Experiencing®, educator, and author of several best-selling books on trauma. His most recent book, An Autobiography of Tra...

2 Heinä 20241h 16min

PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

In this episode of Vital Psychedelic Conversations, Johanna interviews Erika Dyck: author, professor, historian, Vital instructor, and research chair in the History of Health & Social Justice at the U...

28 Kesä 20241h 6min

PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement. After many years of working in community ...

25 Kesä 20241h 8min

PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel thera...

21 Kesä 20241h 17min

PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. W...

18 Kesä 20241h 3min

PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified breathwork facilitator and co-founder of retreat company, The Infinite Center; and Kar...

14 Kesä 20241h 11min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
rss-tiedetta-vai-tarinaa
utelias-mieli
docemilia
sotataidon-ytimessa
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-bios-podcast
rss-ranskaa-raakana
rss-duodecim-lehti
rss-duokkari-ekstra
rss-astetta-parempi-elama-podcast
rss-metsantuntijat-podcast
rss-ilmasto-kriisissa
rss-ylistys-elaimille
rss-sosiopodi